Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
about
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLDVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinOxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles PerspectiveGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsGenetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesDysregulation of iron and copper homeostasis in nonalcoholic fatty liverObesity as an emerging risk factor for iron deficiencyRed meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproductsHigh fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overloadIron and non-alcoholic fatty liver diseaseEffect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging resultsPrevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in patients with thalassemia major in Iran: A meta-analysis study.Quantification of liver fat in the presence of iron overload.Epidemiological associations between iron and cardiovascular disease and diabetes.Hepcidin and the iron enigma in HCV infection.Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levelsHepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial.Obesity promotes alterations in iron recycling.Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine modelIron homeostasis: a new job for macrophages in adipose tissue?Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in LiverBody iron, serum ferritin, and nonalcoholic fatty liver disease.Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension.Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigsQuantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI.Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseDiagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver diseaseRed blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease.Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.R2* estimation using "in-phase" echoes in the presence of fat: the effects of complex spectrum of fat.Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.mTOR regulates cellular iron homeostasis through tristetraprolin.Iron and diabetes riskIron Overload Coordinately Promotes Ferritin Expression and Fat Accumulation in Caenorhabditis elegans.Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice
P2860
Q26748461-4C60A562-B39A-43F9-8ABA-6640D4877C35Q26750865-2FB4021C-140C-4B4D-80D0-593E00E979F3Q26770805-66DB9957-67B2-43F4-8A3F-DF37F8FE2F3BQ26780248-9BDEB539-290F-4084-888D-E5FCCB9DDAA3Q26796448-A864B815-A65F-46D3-BA33-2B8AB1799348Q26798151-10539C1E-6211-4730-A4CC-D30965C366EEQ26828855-B75E9EEC-CB84-471D-8963-8B2B66BB74CFQ26996539-B9E7E793-87E3-4809-86CF-43763990BBEBQ27000369-A8B32A1F-FD72-4DE9-9A61-AA8233C360F1Q27021921-F4F04161-B004-4A37-B543-F799A823952CQ27316857-05438CDD-DB9F-4351-94E6-5F08D65F6BCAQ28070303-D244A08D-08C9-4A73-B7D8-C2B9C3C65DA6Q30559328-B6264A30-99DE-4F1A-BE8F-C854660A6337Q33624121-7569F446-BF58-4A77-A294-ADFB571A5324Q33645229-143BD208-F550-4404-8479-F4EA20494C0FQ33659310-BD28DEB6-5E77-4B37-9BB7-A4710805FC85Q33779089-9F3261FA-24D5-4151-B2C5-8B1CC9DAFD58Q33958622-75C00B20-4621-42B9-8E8D-94E8A4C215D3Q34255487-A9397977-C519-4CEB-86AF-250C37A0C740Q34286733-FC040023-8AD5-457F-ACB8-167B4F907709Q35003800-895B99CA-ABC5-46F4-99A5-310D1D35C063Q35037636-791BC4FE-42FB-44AF-BAA6-2F0069458CAEQ35044427-DEEBBE51-0912-46AB-8662-77D06EBD7213Q35654453-14ECF456-F7B6-4CAE-8ED7-CA6619CC8DCFQ35890608-DC5756D7-F5A9-4010-BAA9-3E217ABE0EBFQ35903869-E6361C9C-2A3A-4A74-9340-10CF0CD30F96Q35921291-24E33104-2554-49BD-AFDF-0BF068AE17C1Q36049336-14A80122-DD66-4541-92AD-6DB81FC2D1BEQ36113235-98C4318B-0B45-4918-9852-30BECB3008D7Q36138443-FFA0C721-0BE7-4FB5-B4AF-D12D643F4A90Q36144451-BD05CE15-DDDE-47EB-9BC8-6FBC3447C8F2Q36277177-F2672411-622A-461E-A11B-D6A09A58D847Q36353620-027366D7-96AE-4737-88EA-AAF1ADB7D2E4Q36373567-EE95E223-9F03-44A1-BACB-9B59FA549738Q36625542-F2B202FD-A835-466C-8578-647BCF714B8AQ36636361-2D5050B2-E2FC-4D9B-A7FA-7C7F6F8D02A0Q36675850-1C2A19D3-0519-41F8-B707-D464A20CE592Q36827829-C09D8978-A8B0-4DC0-A90E-AA409C38B929Q36875611-AC4283A7-F0AD-4908-BF2B-72C9E35D0F9AQ36945115-6D73B038-EC33-4F5C-87C5-69D3E6DA9334
P2860
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@en
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@nl
type
label
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@en
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@nl
prefLabel
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@en
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@nl
P2093
P1476
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.
@en
P2093
Anna Ludovica Fracanzani
Luca Valenti
Paola Dongiovanni
Silvia Fargion
P304
P356
10.1016/J.JHEP.2011.05.008
P577
2011-06-28T00:00:00Z